The medication works across the adult age spectrum
This systematic review of the 13 controlled trials in 3,629 patients, involving 250 deaths, 220 cases of new heart failure, and 38 recurrent heart attacks, found that L-carnitine was associated with: Significant 27% reduction in all-cause mortality (number needed to treat 38) Highly significant 65% reduction in ventricular arrhythmias (number needed to treat 4) Significant 40% reduction in the development of angina (number needed to treat 3) Reduction in infarct size There were numerically fewer myocardial reinfarctions and heart failure cases associated with L-carnitine, but this did not reach statistical significance
The caloric deficit that semaglutide helped create at your starting weight becomes insufficient at your new, lower weight
You might have heard of "niacin flush", or the reddening of skin that causes itchiness
That said, not every potential GLP-1 benefit is proven
116 Study details | Glucagon-like peptide-1 receptor agonist (GLP-1 RA) and diet in inflammatory bowel disease (IBD) patients | ClinicalTrials.gov